600Tip A Randomized Blinded Phase II Study of Ompenaclid (RGX-202-01) Vs Placebo in Combination with FOLFIRI Plus Bevacizumab (BEV) in Patients (pts) with Previously Treated RAS Mutated (rasmt) Advanced/metastatic Colorectal Cancer (Mcrc)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要